He was often tired, had swollen lymph nodes, and actually contracted blood cancer. Fortunately, "this drug" can save his life. The Lord Hospital helps people test bone density and demonstrates a new minimally invasive spinal endoscopic simulation surgery. The American company Sunshine cooperates with FedEx Delivering to the world a new system of vital health care "intestinal" brought by stem cells to protect health
What is genetic testing? Human genes will continue to change with the external environment or other uncertain factors. Through genetic testing, we can understand possible diseases in the body, continuously monitor body changes, prevent risks such as disease progression in advance, and greatly reduce the chance of emergencies. "Hualian Biotechnology", which was transferred from the Industrial Technology Research Institute and has been deeply rooted in Taiwan for 17 years, focuses on the development of genetic testing platforms and services. Chairman Yang Guihua mentioned that it was because he saw the needs of the Taiwanese people and wanted to get closer to the Asian Chinese market. The demand has allowed Hualian, which has independent high-density gene chip research and development capabilities, professional technology and resources, to extend its more complete one-stop genetic testing services through the four major areas of genetic testing: "reproductive medicine, mass Medicine, Oncology, Translational Medicine and Scientific Research Services" provide the public with one-stop companionship in eugenics and anti-cancer from birth to adulthood! Let each family member have a professional team as the strongest backing at different stages of life to care for and protect the health of the whole family at all times. Chairman Yang Guihua of Hualian Biotechnology (Photographed by China Times Electronic News)
The concept of preventive medicine improves the risk control of genetic testing and early screening
Su Hongru, Chief Operating Officer of Hualian Biotechnology, gives an example of preventive medicine The most famous implementation case is Hollywood star Angelina Jolie, who had her breasts removed to prevent the incidence of breast cancer. In addition, with the rise of the concept of preventive medicine, although the fertility rate is declining today, the clinical application of prenatal testing, using sheep crystal slices for genetic testing services for rare diseases, continues to rise! In prenatal and postnatal testing of newborns It is recommended that if prevention and early screening can be done through genetic testing, many risks can be avoided.
A new revolution in early screening of liver cancer! The early diagnosis sensitivity of methylation gene detection increased by 84.2
Liver cancer is a national disease of the Chinese. There are no biomarkers for early screening. Many times, liver cancer is discovered at an advanced stage. The treatment effect is limited and also causes many families to suffer from liver cancer. burden. Chairman Yang Guihua said that Hualian Biotech's "methylation gene detection technology for early screening of liver cancer" can now increase the sensitivity of early diagnosis of liver cancer through only a small amount of blood testing and the use of patented technology of methylation prediction models. to 84.2, patients can also significantly improve their survival rates due to early diagnosis and early treatment.
Dr. Su Hongru said that according to clinical studies, 50% of patients who have been diagnosed with liver cancer cannot be diagnosed through the general liver cancer screening tool AFP (alpha-fetoprotein). Sensitively detects cancer (presenting a false negative); however, highly sensitive liver cancer methylation gene testing can detect 70-80% of patients with liver cancer among 50% of patients who cannot be detected by the test; compared with traditional liver cancer Early screening has been pushed forward to stage 0-1! Implementing the concept of early prevention and early treatment has become a great boon for early screening of liver cancer!
Chief Operating Officer Su Hongru of Hualian Biotechnology (Photographed by China Times Electronic News)
Hualian and Beijing Medical University work together to cultivate industry-university special classes to cultivate talent-connected enterprises
Artificial intelligence and big data are current trends, and it is not easy to cultivate talents in biotechnology. Xie Bangchang, dean of the School of Management at Taipei Medical University, pointed out that in 2014, Peking University officially entered the fields of big data and artificial intelligence, and listed the two as Required courses, "Big Data Technology and Management Institute" and "Post-Bachelor's Degree Program in Big Data Technology and Management" were successively established. Since the school's artificial intelligence courses currently focus on technical aspects and have relatively few industrial aspects, we have cooperated with Hualian to create the "Autumn Class of the Master's Degree in Smart Data Application Industry" to establish a good bridge with enterprises in biotechnology, medical care, health management, etc. , through industry-university cooperation, we can better understand the problems faced by enterprises, and we can better integrate with the industry after graduation.
Finally, Chairman Yang Guihua said that Hualian hopes to help students cooperate with the actual industrial operation model and quickly connect to the biotechnology market and develop their strengths when entering society in the future, saving more preliminary education and training, and at the same time With more resources, we can promote the brand internationally and let the world see the top medical team from Taiwan!
(Provided by China Times Electronic News) Topics: Sheep crystal tablets, Hualian Biotechnology, Hualian Biotechnology Chief Operating Officer Su Hongru, Chairman Yang Guihua, preventive medicine